Virtus Health logo

VRT - Virtus Health Share Price

A$5.93 0.1  0.9%

Last Trade - 4:00am

Sector
Healthcare
Size
Small Cap
Market Cap £262.5m
Enterprise Value £384.2m
Revenue £159.1m
Position in Universe 424th / 1855
Bullish
Bearish
Unlock VRT Revenue
Momentum
Relative Strength (%)
1m +2.54%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -10.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
234.1 261.2 256.5 263.9 280.1 258.9 306.9 306 +2.0%
-1.2 +10.8 -9.8 +3.4 +2.4 -67.9 +227.8 -8.75
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2020, VirtusHealth Ltd revenues increased 19% to A$169.6M. Net incomeincreased 100% to A$29.9M. Revenues reflect HealthcareServices Australia segment increase of 22% to A$136M,Healthcare Services International segment increase of 12%to A$32.8M, Australia segment increase of 22% to A$136M,International segment increase of 12% to A$32.8M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

VRT Revenue Unlock VRT Revenue

Net Income

VRT Net Income Unlock VRT Revenue

Normalised EPS

VRT Normalised EPS Unlock VRT Revenue

PE Ratio Range

VRT PE Ratio Range Unlock VRT Revenue

Dividend Yield Range

VRT Dividend Yield Range Unlock VRT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
VRT EPS Forecasts Unlock VRT Revenue
Profile Summary

Virtus Health Limited is an assisted reproductive services provider engaged in the provision of healthcare services, including fertility services, medical day procedure services and medical diagnostic services. The Company has six operating segments: New South Wales, Queensland, Victoria, Tasmania, Australian Diagnostics and International. It has consolidated its operations into two segments, being an Australian aggregated healthcare services segment (Healthcare Services Australia) and an International healthcare services segment (Healthcare Services International). Its fertility clinics include IVFAustralia, Melbourne IVF, Queensland Fertility Group, Rotunda IVF and Virtus Fertility Centre. Its day hospitals include North Shore Specialist Day Hospital, Spring Hill Specialist Day Hospital, Mackay Specialist Day Hospital, City East Specialist Day Hospital and City West Specialist Day Hospital. It offers general pathology services, as well as specialist fertility and genetic testing.

Directors
Last Annual June 30th, 2020
Last Interim December 31st, 2020
Incorporated February 11, 2008
Public Since June 11, 2013
No. of Shareholders: 9,505
No. of Employees: 1,300
Sector Healthcare
Industry Healthcare Providers & Services
Index S&P/ASX All Ordinaries , S&P/ASX 300 , ASX Small Ordinaries ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 80,389,938
Free Float (0.0%)
Eligible for
ISAs
SIPPs
VRT Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for VRT
Upcoming Events for VRT
Frequently Asked Questions for Virtus Health
What is the Virtus Health share price?

As of 4:00am, shares in Virtus Health are trading at A$5.93, giving the company a market capitalisation of £262.5m. This share price information is delayed by 15 minutes.

How has the Virtus Health share price performed this year?

Shares in Virtus Health are currently trading at A$5.93 and the price has moved by 44.47% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Virtus Health price has moved by 20.66% over the past year.

What are the analyst and broker recommendations for Virtus Health?

Of the analysts with advisory recommendations for Virtus Health, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Virtus Health is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Virtus Health next release its financial results?

Virtus Health is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Virtus Health dividend yield?

The Virtus Health dividend yield is 2.04% based on the trailing twelve month period.

Does Virtus Health pay a dividend?

Last year, Virtus Health paid a total dividend of 0.12, and it currently has a trailing dividend yield of 2.04%. Looking ahead, shares in Virtus Health are due to go ex-dividend on 2021-03-24 and the next dividend pay date is 2021-04-15.

When does Virtus Health next pay dividends?

Virtus Health are due to go ex-dividend on 2021-03-24 and the next dividend pay date is 2021-04-15. The historic dividend yield on Virtus Health shares is currently 2.04%.

How do I buy Virtus Health shares?

To buy shares in Virtus Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Virtus Health?

Shares in Virtus Health are currently trading at A$5.93, giving the company a market capitalisation of £262.5m.

Where are Virtus Health shares listed? Where are Virtus Health shares listed?

Here are the trading details for Virtus Health:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: VRT
What kind of share is Virtus Health?

Based on an overall assessment of its quality, value and momentum, Virtus Health is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Virtus Health share price forecast 2021?

Shares in Virtus Health are currently priced at A$5.93. At that level they are trading at 8.1% discount to the analyst consensus target price of 0.00.

Analysts covering Virtus Health currently have a consensus Earnings Per Share (EPS) forecast of 0.423 for the next financial year.

How can I tell whether the Virtus Health share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Virtus Health. Over the past six months, the relative strength of its shares against the market has been 43.14%. At the current price of A$5.93, shares in Virtus Health are trading at 35.06% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Virtus Health PE Ratio?

The Virtus Health PE ratio based on its reported earnings over the past 12 months is 24.08. The shares are currently trading at A$5.93.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Virtus Health?

Virtus Health's management team is headed by:

Lyndon Hale - EDR
Glenn Powers - CFO
Peter Illingworth - OTH
Sonia Petering - NEC
David Molloy - OTH
Greg Couttas - NID
William Watkins - OTH
Jade Phelan - MDR
Shane Solomon - NID
Richard Banks - MDR
Kate Munnings - CEO
Chris Smedley - MDR
Who are the major shareholders of Virtus Health?

Here are the top five shareholders of Virtus Health based on the size of their shareholding:

Yarra Funds Management Limited Investment Advisor
Percentage owned: 7.88% (6.34m shares)
Paradice Investment Management Pty. Ltd. Investment Advisor
Percentage owned: 7.7% (6.19m shares)
Dimensional Fund Advisors, Ltd. Investment Advisor
Percentage owned: 5.22% (4.20m shares)
Mitsubishi UFJ Financial Group Inc Holding Company
Percentage owned: 4.65% (3.74m shares)
Allan Gray Australia Pty Ltd Investment Advisor
Percentage owned: 4.65% (3.74m shares)
Similar to VRT
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.